Module 1D: Pharmacology Flashcards
absorption
movement of drug from site of administration to blood
enteral (GI tract)
PO, solids vs. liquids, combination drugs, EC, time-release formulations, thin film
parenteral
IV, IM, SQ, topical
injections
intravenous, intramuscular, subcutaneous
IV
barriers to absorption
intramuscular (IM)
usually used for slower absorption
topical
works directly, skin or mucous membrane is barrier to drugs need to get through, skin, eyes, ears, nose, mouth, lungs, rectum, vagina
distribution
drug movement from bloodstream to body tissues and organs
distribution is determined by
blood flow to tissues, drug binding and solubility, ability of drug to enter cells
blood brain barrier
drug passage in CNS prevented by tight junctions between cells of capillary walls
placental drug transfer
drugs transfer through, and how much of the medication can be distributed to affected area; do not want to harm fetus
protein binding
important to check pts protein levels to ensure drug can bind to med, measure albumin levels
metabolism
chemical alteration of drug structure
drug inactivation
increased therapeutic action; activation of prodrugs and increased or decreased toxicity
therapeutic consequences of drug metabolism
accelerated renal drug excretion, drug inactivation, ↑ therapeutic action, activation of prodrugs, ↑ and ↓ toxicity
metabolism factors
age, drug metabolizing enzymes, first pass effect, nutritional status, drugs can compete for metabolism
excretion
removal of drugs from the body (liver metabolizes → biotransformed →kidneys → kidneys → urine)
factors in excretion
age, glomerular filtration, breast milk, other routes
glomerular filtration
healthy kidneys → filter out drugs (limiting duration)
renal failure → intensity and duration increases
onset
therapeutic response time
peak effect
maximal therapeutic effect
duration
length of time the rug is therapeutic for
trough
lowest concentration in pts bloodstream
peak
highest concentration of a drug in pts bloodstream
factors affecting pts response to a drug
age, kidney fxn, liver disease, tolerance, placebo effect, genetic and pharmocogenomics
pharmacodynamics
study of biochemical and physiological effects of drugs on the body and molecular mechanism by which those effects are produced
mechanism of action
relationship between drug concentration and the response in the body
maximal efficacy
largest effect a drug can produce
relative potency
how much drug needs to be given to elicit a response
agonists
mimics body’s own response, activates receptors (e.g., morphine)
antagonists
prevent receptor activation, beneficial effects by blocking (naloxone)
partial agonist
maximum effect is less than that of a full agonist
drug interactions
drug-drug, drug-supplement, drug-food